Peripheral inflammatory markers contributing to comorbidities in autism

Behavioral Sciences

Volumn 6, Issue 4, 2016, Pages

  Jácome, Martha Cecilia Inga ^a   Chacòn, Lilia Maria Morales ^b   Cuesta, Hector Vera ^b   Rizo, Carlos Maragoto ^b   Santiesteban, Mabel Whilby ^c   Hernandez, Lesyanis Ramos ^c   García, Elena Noris ^d   Fraguela, Maria Elena González ^b   Verdecia, Caridad Ivette Fernandez ^b   Hurtado, Yamilé Vegas ^b   Siniscalco, Dario ^e   Gonçalves, Carlos Alberto ^f   De Los Angeles Robinson Agramonte, Maria ^b  

^a UNIVERSITY OF HAVANA   (Cuba)

^b CENTRO INTERNACIONAL DE RESTAURACIÓN NEUROLÓGICA CIREN   (Cuba)

^c Calzada Del Cerro Entre Santa Teresa y Monasterio   (Cuba)

^d Hospital Clinicoquirúrgico Docente Joaquín Albarrán   (Cuba)

^e SECOND UNIVERSITY OF NAPLES   (Italy)

^f FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

Autism spectrum disorders; Behavior; Comorbidities; EEG; Epilepsy; Neuro inflammation; Social interaction

Indexed keywords

EID: 85050458978     PISSN: None     EISSN: 2076328X     Source Type: Journal    
DOI: 10.3390/bs6040029     Document Type: Article

References (65)

1. Lintas, C.; Persico, A.M. Autistic phenotypes and genetic testing: State-of-The-Art for the clinical geneticist. J. Med. Genet. 2009, 46, 1-8.
2. Goines, P.; Haapanen, L.; Boyce, R.; Duncanson, P.; Braunschweig, D.; Delwiche, L.; Hansen, R.; Hertz-Picciotto, I.; Ashwood, P.; van de Water, J. Autoantibodies to cerebellum in children with autism associate with behavior. Brain Behav. Immun. 2011, 25, 514-523.
3. Garay, P.A.; McAllister, A.K. Novel roles for immune molecules in neural development: Implications for neurodevelopmental disorders. Front. Synaptic. Neurosci. 2010, 2, 136.
4. Aktas, O.; Smorodchenko, A.; Brocke, S.; Infante-Duarte, C.; Schulze, T.U.; Vogt, J.; Prozorovski, T.; Meier, S.; Osmanova, V.; Pohl, E.; et al. Neuronal damage in autoimmune neuroinflammation mediated by the death ligand TRAIL. Neuron 2005, 46, 421-432.
5. Arima, Y.; Harada, M.; Kamimura, D.; Park, J.H.; Kawano, F.; Yull, F.E.; Kawamoto, T.; Iwakura, Y.; Betz, U.A.; Marquez, G.; et al. Regional neural activation defines a gateway for autoreactive T cells to cross the blood-brain barrier. Cell 2012, 148, 447-457.
6. Odoardi, F.; Sie, C.; Streyl, K.; Ulaganathan, V.K.; Schlager, C.; Lodygin, D.; Heckelsmiller, K.; Nietfeld, W.; Ellwart, J.; Klinkert, W.E.; et al. T cells become licensed in the lung to enter the central nervous system. Nature 2012, 488, 675-679.
7. Aube, B.; Levesque, S.A.; Pare, A.; Chamma, E.; Kebir, H.; Gorina, R.; Lecuyer, M.A.; Alvarez, J.I.; de Koninck, Y.; Engelhardt, B.; et al. Neutrophils mediate blood-spinal cord barrier disruption in demyelinating neuroinflammatory diseases. J. Immunol. 2014, 193, 2438-2454.
8. Mostafa, G.A.; Al-Ayadhi, L.Y. The relationship between the increased frequency of serum antineuronal antibodies and the severity of autism in children. Eur. J. Paediatr. Neurol. 2012, 16, 464-468.
9. Careaga, M.; Ashwood, P. Autism spectrum disorders: From immunity to behavior. Methods Mol. Biol. 2012, 934, 219-240.
10. Enstrom, A.M.; Onore, C.E.; van de Water, J.A.; Ashwood, P. Differential monocyte responses to TLR ligands in children with autism spectrum disorders. Brain Behav. Immun. 2010, 24, 64-71.
11. Ng, T.K.; Fortino, V.R.; Pelaez, D.; Cheung, H.S. Progress of mesenchymal stem cell therapy for neural and retinal diseases. World J. Stem Cells 2014, 6, 111-119.
12. Tuchman, R.; Hirtz, D.; Mamounas, L.A. NINDS epilepsy and autism spectrum disorders workshop report. Neurology 2013, 81, 1630-1636.
13. Tuchman, R. Autism and social cognition in epilepsy: Implications for comprehensive epilepsy care. Curr. Opin. Neurol. 2013, 26, 214-218.
14. Tuchman, R.; Cuccaro, M. Epilepsy and autism: Neurodevelopmental perspective. Curr. Neurol. Neurosci. Rep. 2011, 11, 428-434.
15. Tuchman, R.; Alessandri, M.; Cuccaro, M. Autism spectrum disorders and epilepsy: Moving towards a comprehensive approach to treatment. Brain Dev. 2010, 32, 719-730.
16. Tuchman, R.; Moshe, S.L.; Rapin, I. Convulsing toward the pathophysiology of autism. Brain Dev. 2009, 31, 95-103.
17. Khandaker, G.M.; Stochl, J.; Zammit, S.; Lewis, G.; Jones, P.B. A population-based longitudinal study of childhood neurodevelopmental disorders, IQ and subsequent risk of psychotic experiences in adolescence. Psychol. Med. 2014, 44, 3229-3238.
18. Tuchman, R.; Rapin, I. Epilepsy in autism. Lancet Neurol. 2002, 1, 352-358.
19. Autism and Developmental Disabilities Monitoring Network Surveillance Year 2008 Principal Investigators; Centers for Disease Control and Prevention. Prevalence of autism spectrum disorders-Autism and Developmental Disabilities Monitoring Network, 14 sites, United States, 2008. MMWR Surveill. Summ. 2012, 61, 1-19.
20. McKnight, W.; Shafer, E.; Wray, C. New autism spectrum criteria proposed: Some who qualify for diagnosis might not after 2013. Pediatr. Ann. 2012, 41, 89.
21. Battle, D.E. Diagnostic and Statistical Manual of Mental Disorders (DSM). Codas 2013, 25, 191-192.
22. Beighley, J.S.; Matson, J.L.; Rieske, R.D.; Jang, J.; Cervantes, P.E.; Goldin, R.L. Comparing challenging behavior in children diagnosed with autism spectrum disorders according to the DSM-IV-TR and the proposed DSM-5. Dev. Neurorehabil. 2013, 16, 375-381.
23. Garcia-Lopez, C.; Narbona, J. Clinical usefulness of IDEA and CARS: Concordance with DSM-IV-TR in children and adolescents with suspicion of PDD. An. Pediatr. (Barc.) 2014, 80, 71-76.
24. George, B.; Padmam, M.S.; Nair, M.K.; Leena, M.L.; Prasanna, G.L.; Russell, P.S. CDC Kerala 11: Diagnosis of autism among children between 2 and 6 y-Comparison of CARS against DSM-IV-TR. Indian J. Pediatr. 2014, 81 (Suppl. 2), S125-S128.
25. Goines, P.; van de Water, J. The immune system's role in the biology of autism. Curr. Opin. Neurol. 2010, 23, 111-117.
26. Carpentier, P.A.; Dingman, A.L.; Palmer, T.D. Placental TNF-Alpha signaling in illness-induced complications of pregnancy. Am. J. Pathol. 2011, 178, 2802-2810.
27. Deverman, B.E.; Patterson, P.H. Cytokines and CNS development. Neuron 2009, 64, 61-78.
28. Ramos, P.S.; Sajuthi, S.; Langefeld, C.D.;Walker, S.J. Immune function genes CD99L2, JARID2 and TPO show association with autism spectrum disorder. Mol. Autism 2012, 3, 4.
29. Mondal, K.; Ramachandran, D.; Patel, V.C.; Hagen, K.R.; Bose, P.; Cutler, D.J.; Zwick, M.E. Excess variants in AFF2 detected by massively parallel sequencing of males with autism spectrum disorder. Hum. Mol. Genet. 2012, 21, 4356-4364.
30. Skafidas, E.; Testa, R.; Zantomio, D.; Chana, G.; Everall, I.P.; Pantelis, C. Predicting the diagnosis of autism spectrum disorder using gene pathway analysis. Mol. Psychiatry 2014, 19, 504-510.
31. Ashwood, P.; Krakowiak, P.; Hertz-Picciotto, I.; Hansen, R.; Pessah, I.; van de Water, J. Elevated plasma cytokines in autism spectrum disorders provide evidence of immune dysfunction and are associated with impaired behavioral outcome. Brain Behav. Immun. 2011, 25, 40-45.
32. De Theije, C.G.; Wu, J.; da Silva, S.L.; Kamphuis, P.J.; Garssen, J.; Korte, S.M.; Kraneveld, A.D. Pathways underlying the gut-To-brain connection in autism spectrum disorders as future targets for disease management. Eur. J. Pharmacol. 2011, 668 (Suppl. 1), S70-S80.
33. De Theije, C.G.; Koelink, P.J.; Korte-Bouws, G.A.; Lopes da, S.S.; Korte, S.M.; Olivier, B.; Garssen, J.; Kraneveld, A.D. Intestinal inflammation in a murine model of autism spectrum disorders. Brain Behav. Immun. 2014, 37, 240-247.
34. Garbett, K.; Ebert, P.J.; Mitchell, A.; Lintas, C.; Manzi, B.; Mirnics, K.; Persico, A.M. Immune transcriptome alterations in the temporal cortex of subjects with autism. Neurobiol. Dis. 2008, 30, 303-311.
35. Manzardo, A.M.; Henkhaus, R.; Dhillon, S.; Butler, M.G. Plasma cytokine levels in children with autistic disorder and unrelated siblings. Int. J. Dev. Neurosci. 2012, 30, 121-127.
36. Onore, C.; van deWater, J.; Ashwood, P. Decreased levels of EGF in plasma of children with autism spectrum disorder. Autism Res. Treat. 2012, 2012, 205362.
37. Singh, V.K.; Warren, R.P.; Odell, J.D.; Cole, P. Changes of soluble interleukin-2, interleukin-2 receptor, T8 antigen, and interleukin-1 in the serum of autistic children. Clin. Immunol. Immunopathol. 1991, 61, 448-455.
38. Al-Ayadhi, L.Y.; Mostafa, G.A. A lack of association between elevated serum levels of S100B protein and autoimmunity in autistic children. J. Neuroinflamm. 2012, 9, 54.
39. Abrahams, B.S.; Geschwind, D.H. Advances in autism genetics: On the threshold of a new neurobiology. Nat. Rev. Genet. 2008, 9, 341-355.
40. Weinstein, A.A.; Deuster, P.A.; Francis, J.L.; Bonsall, R.W.; Tracy, R.P.; Kop, W.J. Neurohormonal and inflammatory hyper-responsiveness to acute mental stress in depression. Biol. Psychol. 2010, 84, 228-234.
41. Petitto, J.M.; Huang, Z.; Meola, D.; Ha, G.K.; Dauer, D. Interleukin-2 and the septohippocampal system: Intrinsic actions and autoimmune processes relevant to neuropsychiatric disorders. Methods Mol. Biol. 2012, 829, 433-443.
42. Pucak, M.L.; Carroll, K.A.; Kerr, D.A.; Kaplin, A.I. Neuropsychiatric manifestations of depression in multiple sclerosis: Neuroinflammatory, neuroendocrine, and neurotrophic mechanisms in the pathogenesis of immune-mediated depression. Dialogues Clin. Neurosci. 2007, 9, 125-139.
43. Vezzani, A.; Friedman, A. Brain inflammation as a biomarker in epilepsy. Biomark. Med. 2011, 5, 607-614.
44. Xu, N.; Li, X.; Zhong, Y. Inflammatory Cytokines: Potential Biomarkers of Immunologic Dysfunction in Autism Spectrum Disorders. Mediat. Inflamm. 2015, 2015, 531518.
45. Goines, P.E.; Ashwood, P. Cytokine dysregulation in autism spectrum disorders (ASD): Possible role of the environment. Neurotoxicol. Teratol. 2013, 36, 67-81.
46. Enstrom, A.M.; van deWater, J.A.; Ashwood, P. Autoimmunity in autism. Curr. Opin. Investig. Drugs 2009, 10, 463-473.
47. Vojdani, A. The Role of Th17 in Neuroimmune Disorders: A Target for CAM Therapy. Part III. Evid.-Based Complement. Altern. Med. 2011, 2011, 548086.
48. Robinson-Agramonte, M.A.; Gonzalez-Quevedo, A.; Goncalvez, C.A. Glial and Axonal Pathology in Multiple Sclerosis. In Immunology to Target Cancer Inflammation and Infections; Kanwar, J.R., Ed.; InTech: Rijeka, Croatia, 2012; pp. 103-131.
49. Banaschewski, T.; Poustka, L.; Holtmann, M. Autism and ADHD across the life span. Differential diagnoses or comorbidity? Nervenarzt 2011, 82, 573-580.
50. Bonus, B.; Assion, H.J.; Deister, A. Coincidence of epilepsy and Asperger syndrome. Case report and review. Nervenarzt 1997, 68, 759-764.
51. Chiang, H.L.; Gau, S.S. Comorbid psychiatric conditions as mediators to predict later social adjustment in youths with autism spectrum disorder. J. Child Psychol. Psychiatry 2015.
52. Areta, J.E. Two main mistakes in classificatory and clinical function of DSM-IV, in the case of differential diagnosis between Asperger and autistic disorder. Vertex 2009, 20, 174-183.
53. Clarke, A.R.; Barry, R.J.; Dupuy, F.E.; Heckel, L.D.; McCarthy, R.; Selikowitz, M.; Johnstone, S.J. Behavioural differences between EEG-defined subgroups of children with Attention-Deficit/Hyperactivity Disorder. Clin. Neurophysiol. 2011, 122, 1333-1341.
54. Ballaban-Gil, K.; Tuchman, R. Epilepsy and epileptiform EEG: Association with autism and language disorders. Ment. Retard. Dev. Disabil. Res. Rev. 2000, 6, 300-308.
55. Musso, T.; Espinoza-Delgado, I.; Pulkki, K.; Gusella, G.L.; Longo, D.L.; Varesio, L. IL-2 induces IL-6 production in human monocytes. J. Immunol. 1992, 148, 795-800.
56. Casanova, M.F.; van Kooten, I.A.; Switala, A.E.; van Engeland, E.H.; Heinsen, H.; Steinbusch, H.W.; Hof, P.R.; Trippe, J.; Stone, J.; Schmitz, C. Minicolumnar abnormalities in autism. Acta Neuropathol. 2006, 112, 287-303.
57. Casanova, M.F.; Sokhadze, E.; Opris, I.; Wang, Y.; Li, X. Autism spectrum disorders: Linking neuropathological findings to treatment with transcranial magnetic stimulation. Acta Paediatr. 2015, 104, 346-355.
58. Bailey, A.R.; Hou, H.; Obregon, D.F.; Tian, J.; Zhu, Y.; Zou, Q.; Nikolic, W.V.; Bengtson, M.; Mori, T.; Murphy, T.; et al. Aberrant T-lymphocyte development and function in mice overexpressing human soluble amyloid precursor protein-Alpha: Implications for autism. FASEB J. 2012, 26, 1040-1051.
59. Bailey, A.; Luthert, P.; Dean, A.; Harding, B.; Janota, I.; Montgomery, M.; Rutter, M.; Lantos, P. A clinicopathological study of autism. Brain 1998, 121, 889-905.
60. Wang, Y.; Sokhadze, E.M.; El-Baz, A.S.; Li, X.; Sears, L.; Casanova, M.F.; Tasman, A. Relative Power of Specific EEG Bands and Their Ratios during Neurofeedback Training in Children with Autism Spectrum Disorder. Front. Hum. Neurosci. 2016, 9, 723.
61. Tuchman, R. Autism and epilepsy: What has regression got to do with it? Epilepsy Curr. 2006, 6, 107-111.
62. Napolioni, V.; Ober-Reynolds, B.; Szelinger, S.; Corneveaux, J.J.; Pawlowski, T.; Ober-Reynolds, S.; Kirwan, J.; Persico, A.M.; Melmed, R.D.; Craig, D.W.; et al. Plasma cytokine profiling in sibling pairs discordant for autism spectrum disorder. J. Neuroinflamm. 2013, 10, 38.
63. Saresella, M.; Marventano, I.; Guerini, F.R.; Mancuso, R.; Ceresa, L.; Zanzottera, M.; Rusconi, B.; Maggioni, E.; Tinelli, C.; Clerici, M. An autistic endophenotype results in complex immune dysfunction in healthy siblings of autistic children. Biol. Psychiatry 2009, 66, 978-984.
64. Tuchman, R.; Cuccaro, M.; Alessandri, M. Autism and epilepsy: Historical perspective. Brain Dev. 2010, 32, 709-718.
65. Robinson-Agramonte, M.A.; Gonzalez-Fraguela, M.E.; Bergado-Rosado, J. Chapter 7 Autism, Development and Neural Plasticity. In Translational Approaches to Autism Spectrum Disorder; Robinson-Agramonte, M.A., Ed.; Springer: Berlin/Heidelberg, Germany, 2015; pp. 119-135.